ARCA biopharma, Inc. – NASDAQ:ABIO
Founder-led company
ARCA biopharma stock price today
$2.48
-0.87
-25.97%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 14 hours
ARCA biopharma stock price monthly change
+0.30%
month
ARCA biopharma stock price quarterly change
+8.77%
quarter
ARCA biopharma stock price yearly change
+59.15%
year
ARCA biopharma key metrics
Market Cap | 34.81M |
Enterprise value | 1.55M |
P/E | -58.02 |
EV/Sales | 8.85 |
EV/EBITDA | -0.17 |
Price/Sales | 197.82 |
Price/Book | 12.82 |
PEG ratio | -3.12 |
EPS | -0.38 |
Revenue | N/A |
EBITDA | -7.94M |
Income | -5.48M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -4090.91% |
Oper. margin | -4977.84% |
Gross margin | 52.27% |
EBIT margin | -4977.84% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeARCA biopharma stock price history
ARCA biopharma stock forecast
ARCA biopharma financial statements
| Jun 2023 | 0 | -958K | |
|---|---|---|---|
| Sep 2023 | 0 | -1.42M | |
| Dec 2023 | 176K | -1.08M | -618.75% |
| Mar 2024 | 0 | -2.00M |
| Jun 2023 | 41083000 | 1.84M | 4.49% |
|---|---|---|---|
| Sep 2023 | 39184000 | 1.21M | 3.1% |
| Dec 2023 | 37861000 | 841K | 2.22% |
| Mar 2024 | 36706000 | 1.58M | 4.31% |
| Jun 2023 | -694K | 0 | 0 |
|---|---|---|---|
| Sep 2023 | -1.66M | 0 | 0 |
| Dec 2023 | -1.05M | 2K | 0 |
| Mar 2024 | -1.52M | 0 | 0 |
ARCA biopharma alternative data
| Aug 2023 | 5 |
|---|---|
| Sep 2023 | 5 |
| Oct 2023 | 5 |
| Nov 2023 | 5 |
| Dec 2023 | 5 |
| Jan 2024 | 5 |
| Feb 2024 | 4 |
| Mar 2024 | 4 |
| Apr 2024 | 4 |
| May 2024 | 4 |
| Jun 2024 | 4 |
| Jul 2024 | 4 |
ARCA biopharma other data
8.06%
-10.07%
of ABIO is owned by hedge funds
1.16M
-1.45M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jul 2024 | 408777 | 0 |
| Patent |
|---|
Application Filling date: 8 Feb 2021 Issue date: 19 Aug 2021 |
Application Filling date: 5 May 2020 Issue date: 27 Aug 2020 |
Application Filling date: 13 Dec 2018 Issue date: 28 Nov 2019 |
-
What's the price of ARCA biopharma stock today?
One share of ARCA biopharma stock can currently be purchased for approximately $2.48.
-
When is ARCA biopharma's next earnings date?
Unfortunately, ARCA biopharma's (ABIO) next earnings date is currently unknown.
-
Does ARCA biopharma pay dividends?
Yes, ARCA biopharma pays dividends and its trailing 12-month yield is 72.73% with 0% payout ratio. The last ARCA biopharma stock dividend of undefined was paid on 4 Sep 2025.
-
How much money does ARCA biopharma make?
ARCA biopharma has a market capitalization of 34.81M.
-
What is ARCA biopharma's stock symbol?
ARCA biopharma, Inc. is traded on the NASDAQ under the ticker symbol "ABIO".
-
What is ARCA biopharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of ARCA biopharma?
Shares of ARCA biopharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are ARCA biopharma's key executives?
ARCA biopharma's management team includes the following people:
- Dr. Michael R. Bristow M.D., Ph.D. Co-Founder, Pres, Chief Executive Officer & Director(age: 80, pay: $441,610)
- Mr. Thomas A. Keuer Chief Operating Officer(age: 66, pay: $402,610)
- Mr. Christopher D. Ozeroff Senior Vice President, Gen. Counsel & Sec.(age: 66, pay: $376,380)
-
Is ARCA biopharma founder-led company?
Yes, ARCA biopharma is a company led by its founder Dr. Michael R. Bristow M.D., Ph.D..
-
How many employees does ARCA biopharma have?
As Jul 2024, ARCA biopharma employs 4 workers.
-
When ARCA biopharma went public?
ARCA biopharma, Inc. is publicly traded company for more then 28 years since IPO on 8 Aug 1997.
-
What is ARCA biopharma's official website?
The official website for ARCA biopharma is arcabio.com.
-
Where are ARCA biopharma's headquarters?
ARCA biopharma is headquartered at 10170 Church Ranch Way, Westminster, CO.
-
How can i contact ARCA biopharma?
ARCA biopharma's mailing address is 10170 Church Ranch Way, Westminster, CO and company can be reached via phone at +7 209402200.
ARCA biopharma company profile:
ARCA biopharma, Inc.
arcabio.comExchange:
NASDAQ
Full time employees:
3
Industry:
Biotechnology
Sector:
Healthcare
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorado Prevention Center, the University of Colorado's Academic Research Organization to develop and commercialize Gencaro. The company was incorporated in 2004 and is headquartered in Westminster, Colorado.
10170 Church Ranch Way
Westminster, CO 80021
Westminster, CO 80021
CIK: 0000907654
ISIN: US00211Y5069
CUSIP: 00211Y506
